Journal profile · GENETICS & HEREDITY
Epigenetics & Chromatin
ISSN 1756-8935 · BioMed Central · ENGLAND · Founded 2008
Epigenetics & Chromatin: CAS Zone 2 · Biology (2025 upgraded edition); impact factor 4.41; fully open access; APC about USD 3,290; median 123 days to acceptance (97 articles, last 24 months); 89 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
Epigenetics & Chromatin is published by BioMed Central and is in Zone 2 of Biology in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Genomics and Chromatin Dynamics, Epigenetics and DNA Methylation and Chromosomal and Genetic Variations, together about 52.5% of its articles. Its main subfields are Molecular Biology. (generated from OpenAlex topic counts and CAS ranking data)
Epigenetics & Chromatin is a peer-reviewed, open access journal that publishes research, and reviews, providing novel mechanistic insights into epigenetic inheritance and chromatin-based interactions. The journal aims to understand how gene and chromosomal elements are regulated and their activities maintained during processes such as cell division, differentiation and environmental alteration. This encompasses but is not limited to studies addressing: Molecular processes and mechanisms, including histone modifications, DNA methylation and modification, structure and mechanism of epigenetic enzymes, regulation of gene expression, histone variants, linker histones. Chromatin structure and dynamics, including structural and modelling studies, chromatin remodeling, nucleosome positioning, structure and mechanism of chromatin related enzymes and complexes, mechanisms of chromatin regulation, higher order chromatin structure. Epigenetic processes, including genomic imprinting, dosis compensation and X-chromosome inactivation, mitotic & meiotic heritability of epigenetic information. Development of new biochemical and computational tools and methods, including single cell epigenomics approaches, novel epigenome analysis methods, bioinformatic technologies in epigenomics research, epigenome editing, computational epigenomics. Biological processes, including developmental epigenetics, cancer epigenetics, neuroepigenetics, non-coding RNA with roles in epigenetics and chromatin biology, plant epigenetics, epigenetics and metabolism, epigenetics and evolution.
From the journal's Aims & Scope
Research area (LetPub): GENETICS & HEREDITY
Editor-in-chief Albert JeltschPublisher website
Editorial board by country: 1 in mainland China (about 2%); most named United States 27, Netherlands 7, United Kingdom 5, Germany 5, Japan 2 (55 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Genomics and Chromatin DynamicsBiochemistry, Genetics and Molecular Biology23.8%
- Epigenetics and DNA MethylationBiochemistry, Genetics and Molecular Biology23.7%
- Chromosomal and Genetic VariationsAgricultural and Biological Sciences5%
- Cancer-related gene regulationBiochemistry, Genetics and Molecular Biology4.7%
- Genetic Syndromes and ImprintingBiochemistry, Genetics and Molecular Biology4.4%
- Developmental Biology and Gene RegulationBiochemistry, Genetics and Molecular Biology4%
- RNA Research and SplicingBiochemistry, Genetics and Molecular Biology3.2%
- RNA modifications and cancerBiochemistry, Genetics and Molecular Biology3%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Biology Zone 2
| Level | Category | Zone |
|---|---|---|
| Major | Biology | Zone 2 |
| Minor | Genetics & Heredity | Zone 2 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Biology Zone 2
| Level | Category | Zone |
|---|---|---|
| Major | Biology | Zone 2 |
| Minor | Genetics & Heredity | Zone 3 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Biology Zone 2
| Level | Category | Zone |
|---|---|---|
| Major | Biology | Zone 2 |
| Minor | Genetics & Heredity | Zone 3 |
Top journal: noReview journal: no
Database indexing
SCIEScopusDOAJLetPub
International journal early-warning lists: not listed in any editionLetPub
Indexing the journal's website claims
MEDLINEEmbaseCASPublisher website
Other: Google Scholar, ProQuest, Dimensions, CNKI, Baidu, Naver, OCLC, Portico, CLOCKSS
As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 4.41LetPub ·
- Impact factor (publisher) 2025
- 4.4Publisher website ·
- 5-year impact factor (publisher) 2025
- 4.7Publisher website ·
- CiteScore 2026-06
- 6.3LetPub ·
- SJR 2026-06
- 1.63LetPub ·
- SNIP 2026-06
- 1.06LetPub ·
- h-index
- 40LetPub ·
- h-index
- 95OpenAlex ·
- i10-index
- 659OpenAlex ·
- 2-year mean citedness
- 5.95OpenAlex ·
- Self-citation rate
- 2.3%LetPub ·
- Share of gold OA articles
- 100%LetPub ·
Volume
- Articles per year
- 86LetPub ·
- Downloads per year (publisher) 2025
- 976,900Publisher website ·
Articles by year OpenAlex count · 1,058 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 45 | 45 | 13 |
| 2025 | 89 | 89 | 596 |
| 2024 | 39 | 39 | 420 |
| 2023 | 50 | 50 | 650 |
| 2022 | 41 | 41 | 1,015 |
| 2021 | 58 | 58 | 1,861 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with Crossref · to
123 daysMedian, submission to acceptance · P25–P75 93 days – 163 days
- Acceptance to online
- median 21 days (97 articles)
- Submission to online
- median 149 days
- Sample
- 97 articles with submission and acceptance dates (143 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- over 12 weeksLetPub ·
- Submission to first decision
- 2 daysPublisher website ·
- Submission to publication (journal-reported)
- about 12 weeksDOAJ ·
- Peer review
- Single anonymous peer reviewDOAJ
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Fully open accessDOAJ
Every article is open access; authors usually pay an article processing charge (APC).
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| DOAJ | EUR 2,790 / USD 3,290 / GBP 2,490 | Yes | CC BY, CC BY-NC-ND | |
| OpenAlex | USD 3,190 / EUR 2,690 / GBP 2,390 | — | — | |
| LetPub | GBP 2,290 / USD 3,090 / EUR 2,590 | Yes | — | |
| Publisher website | GBP 2,490 / USD 3,290 / EUR 2,790 | — | — |
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
What to prepare1 items from the author guidelines
- Suggested reviewers
- Optional
Policy excerpts from the journal's websiteData availability, License & copyright, Open access, Peer review
- Data availability Formatting the 'Availability of data and materials' section of your manuscript
The following format for the 'Availability of data and materials section of your manuscript should be used:
Source ↗Publisher website ·- License & copyright Licensing and copyright
Creative Commons licences Open access articles in Springer Nature journals are published under Creative Commons licences. These provide an industry-standard framework to support easy re-use of open access material. Under Creative Commons licences, authors retain copyright of their articles. Epigenetics & Chromatin articles are published open access under a CC BY-NC-ND (Creative Commons Attribution…
Source ↗Publisher website ·- Open access Benefits of open access
Publishing open access (OA) offers a number of benefits, including greater reach and readership for your work: Cited more 1.6x more citations of OA articles than non-OA articles across all subjects Downloaded more 4x more downloads of OA articles than non-OA articles Greater impact 2.5x more Altmetric attention. OA articles attracted 1.9x more news mentions and 1.2x more policy mentions Open acces…
Source ↗Publisher website ·- Peer review Peer review policy
Peer review is the process used to evaluate the quality of a manuscript before publication. Independent researchers in the relevant field assess submitted manuscripts to check their validity and robustness. Their feedback guides editors in making publication decisions. Typically, two or more experts evaluate each manuscript based on three main criteria: scientific robustness: is the research metho…
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- BioMed Central
- Country or region
- ENGLAND
- Language
- English
- Founded
- 2008
- ISSN
- 1756-8935
- Official links
- Journal homepage ↗DOAJ
- Submission system ↗LetPub
- Author guidelines ↗LetPub
- Aims & Scope ↗LetPub
- Special issues ↗Publisher website
- APC information ↗DOAJ
- Fee waivers ↗DOAJ
- Open access statement ↗DOAJ
- License & copyright ↗DOAJ
- Peer review process ↗LetPub
- Editorial board ↗LetPub
- Plagiarism policy ↗DOAJ
FAQ
Frequently asked questions about Epigenetics & Chromatin
What CAS zone is Epigenetics & Chromatin in?
In the 2025 upgraded edition of the CAS Journal Ranking, Epigenetics & Chromatin is in Zone 2 of Biology, and in Zone 2 of the minor category Genetics & Heredity. In the 2026 Xinrui edition it is in Zone 2 of Biology. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Epigenetics & Chromatin?
The latest impact factor listed by LetPub is 4.41; CiteScore 6.3, h-index 95.
How long does peer review take at Epigenetics & Chromatin?
Based on the dates recorded on 97 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 123 days (interquartile range 93–163 days); authors report an average review time of over 12 weeks. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
Where are the editorial board members of Epigenetics & Chromatin based?
Of the 55 board members whose country the journal's board page names, 1 (about 2%) are in mainland China; the countries named most often are United States (27), Netherlands (7) and United Kingdom (5). Counted from the institutions listed on the board page; for reference only.
Which databases index Epigenetics & Chromatin?
According to LetPub and DOAJ records, Epigenetics & Chromatin is indexed in SCIE, Scopus and DOAJ. The journal's website also lists MEDLINE, Embase and CAS; that list has not been checked against each database.
Is Epigenetics & Chromatin open access, and what is the APC?
Epigenetics & Chromatin is a fully open-access journal. APC about USD 3,290.
Sources and updates
The facts on this page come from LetPub, OpenAlex, DOAJ, Publisher website; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-24). Last updated: .